Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CP-24879 hydrochloride (CP-24879 HCl) 是选择性的 delta5D/delta6D 联合抑制剂。它能显著降低肝细胞内脂质积聚和炎症损伤。它在脂肪-1 和 ω-3 处理的肝细胞中表现出优越的抗脂肪变性和抗炎作用,可用于非酒精性脂肪性肝炎的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 348 | 现货 | ||
5 mg | ¥ 955 | 现货 | ||
10 mg | ¥ 1,530 | 现货 | ||
25 mg | ¥ 2,890 | 现货 | ||
50 mg | ¥ 4,330 | 现货 | ||
100 mg | ¥ 6,180 | 现货 | ||
500 mg | ¥ 12,600 | 6-8周 | ||
1 mL * 10 mM (in DMSO) | ¥ 996 | 现货 |
产品描述 | CP-24879 hydrochloride (CP-24879 HCl), a Δ5D/Δ6D dual-inhibitor, can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 hydrochloride exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes. |
靶点活性 | Δ5D:0.67 μM (ABMC-7 cells), Δ5D:3.4 μM (Liver microsomes), Δ6D:0.56 μM(ABMC-7 cells), Δ6D:0.56 μM(Liver microsomes) |
体外活性 | CP-24879 hydrochloride (0-10 μM, 16 h) blocked LPS-induced expression of inflammatory cytokines in a concentration-dependent manner and showed the inhibitory responses on oleic acid-induced triglyceride accumulation in hepatocytes[2]. CP-24879 hydrochloride (0-10 μM, 4 days) inhibited Δ6 + Δ5 desaturase activities in a concentration-dependent manner, with a concentration-dependent depletion of AA and a decrease in Leukotriene C4 (LTC4) production, and did not inhibit either 5-lipoxygenase or LTC4 synthase activity[4]. |
体内活性 | In Chow-fed and EFAD Balb/C mice, CP-24879 hydrochloride (3 mg/kg, i.p.) inhibited approximately 80% combined Δ6 + Δ5 desaturase activities, causing depletion of AA in the livers of chow-fed mice and preventing repletion of AA in the livers of EFAD mice, and increased OA and LA, with a higher ratio of LA/AA in the livers of mice injected with CP-24879 versus saline (4.70 vs 2.00, Chow-fed mice; 2.46 vs 1.40, EFAD mice; respectively)[4]. |
别名 | CP-24879 HCl |
分子量 | 215.72 |
分子式 | C11H18ClNO |
CAS No. | 10141-51-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (254.96 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.6356 mL | 23.1782 mL | 46.3564 mL | 115.891 mL |
5 mM | 0.9271 mL | 4.6356 mL | 9.2713 mL | 23.1782 mL | |
10 mM | 0.4636 mL | 2.3178 mL | 4.6356 mL | 11.5891 mL | |
20 mM | 0.2318 mL | 1.1589 mL | 2.3178 mL | 5.7945 mL | |
50 mM | 0.0927 mL | 0.4636 mL | 0.9271 mL | 2.3178 mL | |
100 mM | 0.0464 mL | 0.2318 mL | 0.4636 mL | 1.1589 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CP-24879 hydrochloride 10141-51-2 Others CP24879 CP-24879 Fatty acid desaturase inhibitor Anti-inflammatory active Ferroptosis CP-24879 HCl CP 24879 Hydrochloride CP 24879 CP-24879 Hydrochloride CP 24879 hydrochloride inhibit CP24879 Hydrochloride CP24879 hydrochloride Non-alcoholic steatohepatitis Inhibitor inhibitor